http://www.iii.co.uk/investment/detail?code=cotn:SLN.L&display=news http://www.iii.co.uk/investment/detail?code=cotn:SLN.L&display=news&action=article&articleid=8588862&from=rss FOR IMMEDIATE RELEASE Atu027, a First in Class RNAi Therapy, Demonstrates Potential Antitumour Activity in Cancer Patients and Possible Biomarker Identified Silence Therapeutics to Announce New Data from Phase I Study of Atu027 in Solid Tumours At 2012 ASCO Annual Meeting ... Thu, 17 May 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:SLN.L&display=news&action=article&articleid=8584435&from=rss FOR IMMEDIATE RELEASE Publication of 2011 Annual Report and Notice of AGM London, May 14, 2012 - Silence Therapeutics Plc (AIM: SLN), a leading international RNAi therapeutics company, announces that it has today published and sent to shareholders the Annual Report and Accounts for... Mon, 14 May 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:SLN.L&display=news&action=article&articleid=8575371&from=rss FOR IMMEDIATE RELEASE Silence Therapeutics' Partner, Quark Pharmaceuticals, extends its agreement with Pfizer to develop one of its compounds containing Silence's AtuRNAi in a new indication London, 3 May 2012 - Silence Therapeutics Plc (AIM: SLN), a leading international RNAi... Thu, 03 May 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:SLN.L&display=news&action=article&articleid=8533081&from=rss SILENCE THERAPEUTICS plc ("Silence Therapeutics", "Silence", "the Company" or "the Group") UNAUDITED PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2011 London, 21 March 2012 - Silence Therapeutics Plc (AIM: SLN), a leading international RNAi therapeutics company, today announces... Wed, 21 Mar 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:SLN.L&display=news&action=article&articleid=8530197&from=rss FOR IMMEDIATE RELEASE Notification of Preliminary Results London, UK, 19 March, 2012 - Silence Therapeutics plc (AIM: SLN) ("Silence" or "the Company"), a leading RNA interference (RNAi) therapeutics company, today announces that it will issue its preliminary results for the full... Mon, 19 Mar 2012 07:00:00 GMT